Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans.

Bhandari S, Peri A, Cranston I, McCool R, Shaw A, Glanville J, Petrakova L, O'Reilly K.

Clin Endocrinol (Oxf). 2017 Jun;86(6):761-771. doi: 10.1111/cen.13315. Epub 2017 Mar 27. Review.

PMID:
28214374
2.

Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia.

Verbalis JG, Grossman A, Höybye C, Runkle I.

Curr Med Res Opin. 2014 Jul;30(7):1201-7. doi: 10.1185/03007995.2014.920314. Epub 2014 May 14. Review.

PMID:
24809970
3.

Conivaptan for treatment of hyponatremia in neurologic and neurosurgical adults.

Buckley MS, Patel SA, Hattrup AE, Kazem NH, Jacobs SC, Culver MA.

Ann Pharmacother. 2013 Sep;47(9):1194-200. doi: 10.1177/1060028013503126. Review.

PMID:
24259735
4.

Clinical review: the use of vaptans in clinical endocrinology.

Peri A.

J Clin Endocrinol Metab. 2013 Apr;98(4):1321-32. doi: 10.1210/jc.2012-4082. Epub 2013 Feb 11. Review.

PMID:
23401044
5.

Vasopressin antagonists: Pharmacotherapy for the treatment of heart failure.

Reilly T, Schork MR.

Ann Pharmacother. 2010 Apr;44(4):680-7. doi: 10.1345/aph.1M660. Review.

PMID:
20332337
6.

Water in health and disease: new aspects of disturbances in water metabolism.

Peters HP, Robben JH, Deen PM, Wetzels JF.

Neth J Med. 2007 Oct;65(9):325-32.

7.

Recognition and treatment of hyponatremia in acutely ill hospitalized patients.

Patel GP, Balk RA.

Clin Ther. 2007 Feb;29(2):211-29. Review.

PMID:
17472815
8.

Hyponatremia: current treatment strategies and the role of vasopressin antagonists.

Cawley MJ.

Ann Pharmacother. 2007 May;41(5):840-50. Epub 2007 Apr 3. Review.

PMID:
17405824

Supplemental Content

Loading ...
Support Center